Weight Loss
-
Health Ministry warns of unproven weight loss products
GENEVA, July 22 — A warning from the Health Ministry on July 21 has thrown a spotlight on the shaky scientific foundation…
-
Ismail Fazil Critiques Unverified Weight Loss Claims
MALE, July 22 — A Maldivian exercise science coach has publicly taken aim at the TikTok-fueled marketing of quick weight loss products,…
-
Experts Say Stress Hormone Cortisol Drives Weight Gain Beyond Diet
Gurugram, June 19 — The number on the scale keeps climbing. The diet looks clean. The workout routine is consistent. Yet for…
-
Stress, Sleep, Hormones: Why You Gain Weight Despite Not Overeating
Gurugram, June 19 — For many people, the struggle to lose weight or maintain a healthy weight is a constant battle, despite…
-
New Weight-Loss Drug Mazdutide Shows Promising Results In Late Trials
A collaborative effort between U.S. drugmaker Eli Lilly and Chinese biotech Innovent Biologics has produced mazdutile, a once‑weekly injectable designed to address…
-
Eli Lilly Mazdutide Weight Loss Drug Shows Promise
China, May 21, 2025 — infopulsetoday.com — New clinical data released in May 2025 show that the investigational drug mazdutide, a once-weekly…
-
Diabetes Drugs Show Promise in Treating Addiction and Cravings
A class of medications originally developed for diabetes is now being investigated for a completely different purpose: treating addiction. GLP-1 receptor agonists,…
-
GLP-1 Receptor Agonists Show Promise in Diabetes and Obesity Treatment
As of March 25, 2025, a class of drugs called GLP-1 receptor agonists continues to gain attention for their expanding role in…
-
Novo Nordisk maintains global leadership in diabetes and obesity care innovation
On February 3, 2025, Novo Nordisk A/S, a Danish multinational pharmaceutical company, continued to make its mark in the health industry as…
-
Pfizer Drug Ponsegromab Boosts Weight in Cachexia Trial
Cancer patients losing dangerous amounts of weight have long had few medical options. A monoclonal antibody called ponsegromab might change that. Pfizer…
-
New Dual-Action Diabetes Drug Hits US Market with Promise
Millions of Americans who live with type 2 diabetes now have an additional medication to consider. Tir tirzepatide, cleared by the U.S.…
-
FDA Approves Tirzepatide for Diabetes Treatment in May 2022
Revolutionary Diabetes Treatment: Mounjaro, a Dual GIP/GLP-1 Agonist, Makes Strides In the realm of diabetes treatment, a novel medication named Mounjaro, developed…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
-
Moderna’s mRNA Platform Enables Rapid Personalized Cancer Vaccines
-
Evaluating Skyrizi’s Efficacy and Market Position in Crohn’s Disease Care
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman: Why Medical Costs Demand an 8-Month Emergency Fund
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds















